198 related articles for article (PubMed ID: 17948978)
21. N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonists.
Tsai Y; Dukat M; Slassi A; MacLean N; Demchyshyn L; Savage JE; Roth BL; Hufesein S; Lee M; Glennon RA
Bioorg Med Chem Lett; 2000 Oct; 10(20):2295-9. PubMed ID: 11055342
[TBL] [Abstract][Full Text] [Related]
22. Cyclopropyl-tryptamine analogues: synthesis and biological evaluation as 5-HT(6) receptor ligands.
Szalata C; Szymoniak J; Fabis F; Butt-Gueulle S; Rault S; Bertus P; Gérard S; Sapi J
ChemMedChem; 2013 Jan; 8(1):70-3. PubMed ID: 23129513
[TBL] [Abstract][Full Text] [Related]
23. The design and synthesis of a tricyclic single-nitrogen scaffold that serves as a 5-HT2C receptor agonist.
Huck BR; Llamas L; Robarge MJ; Dent TC; Song J; Hodnick WF; Crumrine C; Stricker-Krongrad A; Harrington J; Brunden KR; Bennani YL
Bioorg Med Chem Lett; 2006 Aug; 16(15):4130-4. PubMed ID: 16750364
[TBL] [Abstract][Full Text] [Related]
24. Discovery of a novel azepine series of potent and selective 5-HT2C agonists as potential treatments for urinary incontinence.
Brennan PE; Whitlock GA; Ho DK; Conlon K; McMurray G
Bioorg Med Chem Lett; 2009 Sep; 19(17):4999-5003. PubMed ID: 19646865
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a potent, orally available, and isoform-selective retinoic acid beta2 receptor agonist.
Lund BW; Piu F; Gauthier NK; Eeg A; Currier E; Sherbukhin V; Brann MR; Hacksell U; Olsson R
J Med Chem; 2005 Dec; 48(24):7517-9. PubMed ID: 16302793
[TBL] [Abstract][Full Text] [Related]
26. Discovery and characterization of 4'-(2-furyl)-N-pyridin-3-yl-4,5'-bipyrimidin-2'-amine (LAS38096), a potent, selective, and efficacious A2B adenosine receptor antagonist.
Vidal B; Nueda A; Esteve C; Domenech T; Benito S; Reinoso RF; Pont M; Calbet M; López R; Cadavid MI; Loza MI; Cárdenas A; Godessart N; Beleta J; Warrellow G; Ryder H
J Med Chem; 2007 May; 50(11):2732-6. PubMed ID: 17469811
[TBL] [Abstract][Full Text] [Related]
27. Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G alpha s.
Dupuis DS; Mannoury la Cour C; Chaput C; Verrièle L; Lavielle G; Millan MJ
Eur J Pharmacol; 2008 Jul; 588(2-3):170-7. PubMed ID: 18511034
[TBL] [Abstract][Full Text] [Related]
28. Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist.
Ito S; Satoh A; Nagatomi Y; Hirata Y; Suzuki G; Kimura T; Satow A; Maehara S; Hikichi H; Hata M; Kawamoto H; Ohta H
Bioorg Med Chem; 2008 Nov; 16(22):9817-29. PubMed ID: 18849168
[TBL] [Abstract][Full Text] [Related]
29. 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 3: Synthesis, metabolic stability, and biological evaluation of optically active analogs.
Asada M; Obitsu T; Kinoshita A; Nagase T; Yoshida T; Yamaura Y; Takizawa H; Yoshikawa K; Sato K; Narita M; Nakai H; Toda M; Tobe Y
Bioorg Med Chem; 2010 May; 18(9):3212-23. PubMed ID: 20385498
[TBL] [Abstract][Full Text] [Related]
30. Discovery of biaryl anthranilides as full agonists for the high affinity niacin receptor.
Shen HC; Ding FX; Luell S; Forrest MJ; Carballo-Jane E; Wu KK; Wu TJ; Cheng K; Wilsie LC; Krsmanovic ML; Taggart AK; Ren N; Cai TQ; Deng Q; Chen Q; Wang J; Wolff MS; Tong X; Holt TG; Waters MG; Hammond ML; Tata JR; Colletti SL
J Med Chem; 2007 Dec; 50(25):6303-6. PubMed ID: 17994679
[TBL] [Abstract][Full Text] [Related]
31. Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists.
Kiesman WF; Zhao J; Conlon PR; Dowling JE; Petter RC; Lutterodt F; Jin X; Smits G; Fure M; Jayaraj A; Kim J; Sullivan G; Linden J
J Med Chem; 2006 Nov; 49(24):7119-31. PubMed ID: 17125264
[TBL] [Abstract][Full Text] [Related]
32. 1-(1-Naphthyl)piperazine as a novel template for 5-HT6 serotonin receptor ligands.
Lee M; Rangisetty JB; Pullagurla MR; Dukat M; Setola V; Roth BL; Glennon RA
Bioorg Med Chem Lett; 2005 Mar; 15(6):1707-11. PubMed ID: 15745826
[TBL] [Abstract][Full Text] [Related]
33. Discovery of trans-4-[1-[[2,5-Dichloro-4-(1-methyl-3-indolylcarboxamido)phenyl]acetyl]-(4S)-methoxy-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid: an orally active, selective very late antigen-4 antagonist.
Muro F; Iimura S; Sugimoto Y; Yoneda Y; Chiba J; Watanabe T; Setoguchi M; Iigou Y; Matsumoto K; Satoh A; Takayama G; Taira T; Yokoyama M; Takashi T; Nakayama A; Machinaga N
J Med Chem; 2009 Dec; 52(24):7974-92. PubMed ID: 19891440
[TBL] [Abstract][Full Text] [Related]
34. The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibitors.
Yuan C; St Jean DJ; Liu Q; Cai L; Li A; Han N; Moniz G; Askew B; Hungate RW; Johansson L; Tedenborg L; Pyring D; Williams M; Hale C; Chen M; Cupples R; Zhang J; Jordan S; Bartberger MD; Sun Y; Emery M; Wang M; Fotsch C
Bioorg Med Chem Lett; 2007 Nov; 17(22):6056-61. PubMed ID: 17919905
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and evaluation of thiazole carboxamides as vanilloid receptor 1 (TRPV1) antagonists.
Xi N; Bo Y; Doherty EM; Fotsch C; Gavva NR; Han N; Hungate RW; Klionsky L; Liu Q; Tamir R; Xu S; Treanor JJ; Norman MH
Bioorg Med Chem Lett; 2005 Dec; 15(23):5211-7. PubMed ID: 16203144
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, structure-activity relationship, and receptor pharmacology of a new series of quinoline derivatives acting as selective, noncompetitive mGlu1 antagonists.
Mabire D; Coupa S; Adelinet C; Poncelet A; Simonnet Y; Venet M; Wouters R; Lesage AS; Van Beijsterveldt L; Bischoff F
J Med Chem; 2005 Mar; 48(6):2134-53. PubMed ID: 15771457
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of piperazinylpyrimidinones as novel selective 5-HT(2C) agonists.
Andrews MD; Green MP; Allerton CM; Batchelor DV; Blagg J; Brown AD; Gordon DW; McMurray G; Millns DJ; Nichols CL; Watson L
Bioorg Med Chem Lett; 2009 Sep; 19(18):5346-50. PubMed ID: 19692241
[TBL] [Abstract][Full Text] [Related]
38. 5-HT2C receptor agonists with potential anorectic activity.
Yoon G; Jeong HJ; Kim JJ; Cheon SH
Arch Pharm Res; 2008 Aug; 31(8):989-94. PubMed ID: 18787786
[TBL] [Abstract][Full Text] [Related]
39. Disposition and metabolism of almotriptan in rats, dogs and monkeys.
Aubets J; Cardenas A; Salva M; Jansat JM; Martinez-Tobed A; Palacios JM
Xenobiotica; 2006 Sep; 36(9):807-23. PubMed ID: 16971345
[TBL] [Abstract][Full Text] [Related]
40. Discovery of a spiroindane based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor agonist.
He S; Ye Z; Dobbelaar PH; Sebhat IK; Guo L; Liu J; Jian T; Lai Y; Franklin CL; Bakshi RK; Dellureficio JP; Hong Q; Tsou NN; Ball RG; Cashen DE; Martin WJ; Weinberg DH; Macneil T; Tang R; Tamvakopoulos C; Peng Q; Miller RR; Stearns RA; Chen HY; Chen AS; Strack AM; Fong TM; Macintyre DE; Wyvratt MJ; Nargund RP
Bioorg Med Chem Lett; 2010 Apr; 20(7):2106-10. PubMed ID: 20207541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
